A member of the PDGFR-family receptor tyrosine kinase (also called type III receptor tyrosine kinases), FLT3, has been shown to be deregulated in acute myeloid leukemia (AML) and in a small portion of acute lymphoblastic leukemia [1, 2]. The gene discussed is SGCG; the disease is acute myeloid leukemia.